Author:
Balzarini J.,Stet L.,Matsuda A.,Wiebe L.,Knauss E.,Clercq E. De
Reference6 articles.
1. De Clercq, E., Cools, M., Balzarini, J., Snoeck, R., Andrei, G., Hosoya, M., Shigeta, S., Ueda, T., Minak-awa, N., and Matsuda, A. Antiviral activities of S-ethynyl-l-β-D-ribofuranosylimidazole-carboxamide and related compounds. Antimicrob. Agents Chemother. 35: 679–684 (1991).
2. Balzarini, J., Karlsson, A., Wang, L., Bohman, C., Horská, K., Votruba, I., Fridland, A., Van Aerschot, A., Herdewijn, P., and De Clercq, E. EICAR (5-ethynyl-l-β-D-ribofuranosylimidazole-carboxamide). A novel potent inhibitor of inosinate dehydrogenase activity and guanylate biosynthesis. J. Biol. Chem. 268: 24591–24598 (1993).
3. Hatse, S., De Clercq, E., and Balzarini, J. Evidence for distinction of the differentiation-inducing activities and cytostatic properties of 9-(2-phosphonylmethoxyethyl)adenine and a variety of differentiation-inducing agents in human erythroleukemia K562 cells. Mol. Pharmacol. 50: 1231–1242 (1996).
4. Matsuda, A., Minakawa, N., Sasaki, T., and Ueda, T. The design, synthesis and antileukemic activity of 5-alkynyl-1-β-D-ribofuranosylimidazole-carboxamides. Chem. Pharm. Bull. 36: 2730–2733 (1988).
5. Balzarini, J., Lee, C.-K., Schols, D., and De Clercq, E. l-β-D-Ribofuranosyl-l,2,4-triazole-3-carboxamide (ribavirin) and 5-ethynyl-l-β-D-ribofuranosylimidazole-4-carboxamide (EICAR) markedly potentiate the inhibitory effect of 2′,3′-dideoxyinosine on human immunodeficiency virus in peripheral blood lymphocytes. Biochem. Biophys. Res. Commun. 178: 563–569 (1991).
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献